Unknown

Dataset Information

0

A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus.


ABSTRACT: The recent threats of influenza epidemics and pandemics have prioritized the development of a universal vaccine that offers protection against a wider variety of influenza infections. Here, we demonstrate a genetically modified virus-like particle (VLP) vaccine, referred to as H5M2eN1-VLP, that increased the antigenic content of NA and induced rapid recall of antibody against HA(2) after viral infection. As a result, H5M2eN1-VLP vaccination elicited a broad humoral immune response against multiple viral proteins and caused significant protection against homologous RG-14 (H5N1) and heterologous A/California/07/2009 H1N1 (CA/07) and A/PR/8/34 H1N1 (PR8) viral lethal challenges. Moreover, the N1-VLP (lacking HA) induced production of a strong NA antibody that also conferred significant cross protection against H5N1 and heterologous CA/07 but not PR8, suggesting the protection against N1-serotyped viruses can be extended from avian-origin to CA/07 strain isolated in humans, but not to evolutionally distant strains of human-derived. By comparative vaccine study of an HA-based VLP (H5N1-VLP) and NA-based VLPs, we found that H5N1-VLP vaccination induced specific and strong protective antibodies against the HA(1) subunit of H5, thus restricting the breadth of cross-protection. In summary, we present a feasible example of direction of VLP vaccine immunity toward NA and HA(2), which resulted in cross protection against both seasonal and pandemic influenza strains, that could form the basis for future design of a better universal vaccine.

SUBMITTER: Wu CY 

PROVIDER: S-EPMC3413679 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus.

Wu Chia-Ying CY   Yeh Yi-Chun YC   Chan Jia-Tsrong JT   Yang Yu-Chih YC   Yang Ji-Rong JR   Liu Ming-Tsan MT   Wu Ho-Sheng HS   Hsiao Pei-Wen PW  

PloS one 20120807 8


The recent threats of influenza epidemics and pandemics have prioritized the development of a universal vaccine that offers protection against a wider variety of influenza infections. Here, we demonstrate a genetically modified virus-like particle (VLP) vaccine, referred to as H5M2eN1-VLP, that increased the antigenic content of NA and induced rapid recall of antibody against HA(2) after viral infection. As a result, H5M2eN1-VLP vaccination elicited a broad humoral immune response against multip  ...[more]

Similar Datasets

| S-EPMC3754050 | biostudies-literature
| S-EPMC3967826 | biostudies-other
| S-EPMC3848947 | biostudies-literature
| S-EPMC4518248 | biostudies-literature
| S-EPMC5670106 | biostudies-literature
| S-EPMC6096824 | biostudies-literature
| S-EPMC2864737 | biostudies-literature
| S-EPMC7774956 | biostudies-literature
| S-EPMC3052313 | biostudies-literature
| S-EPMC4896531 | biostudies-other